Track Chair: Eric Eskioglu 

This panel delves into the evolving landscape of AI compliance and innovation within the pharmaceutical industry. As AI continues to drive breakthroughs in drug discovery, patient engagement, and personalized medicine, it also brings unique challenges in regulatory compliance, data privacy, and ethical considerations. Our panel of industry leaders will explore strategies to balance regulatory requirements with rapid technological advancements, sharing insights on navigating compliance frameworks while fostering innovation. Join us to gain a forward-looking perspective on how pharma can leverage AI responsibly and effectively to transform patient outcomes and streamline operations.